Syra Health Corp. Class A Common Stock (SYRA)
USD 0.38
(-3.8%)
USD 0.38
(-3.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -2.75 Million | -2.24 Million | -88.19 Thousand | - |
| Net Income | -2.93 Million | -2.11 Million | -3280.00 | -51.2 Thousand |
| Depreciation & Amortization | 48.77 Thousand | 14.84 Thousand | 207.00 | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 32.83 Thousand | 2910.00 | - | 1200.00 |
| Change in working capital | -23.41 Thousand | -763.29 Thousand | -112.38 Thousand | 50 Thousand |
| Other non-cash items | 121.08 Thousand | 619.63 Thousand | 27.25 Thousand | - |
| Investing Cash Flow | -15.25 Thousand | -121.26 Thousand | -6289.00 | - |
| Investments in PPE | -15.25 Thousand | -121.26 Thousand | -6289.00 | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 6.05 Million | 2.26 Million | 191.5 Thousand | 36 Thousand |
| Debt repayment | -518.75 Thousand | -736.47 Thousand | -300.00 | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 5.33 Million | 2.32 Million | 300.00 | - |
| Other Financing Activities | 200.01 Thousand | -790.31 Thousand | 191.2 Thousand | 36 Thousand |
| Accounts receivables | -110.16 Thousand | -940.47 Thousand | -260.62 Thousand | - |
| Accounts payables | 27.4 Thousand | 309.85 Thousand | 125.73 Thousand | - |
| Inventory | - | - | - | - |
| Other working capital | 180.43 Thousand | -132.68 Thousand | 22.51 Thousand | 50 Thousand |
| Cash at beginning of period | 3344.00 | 100.01 Thousand | 3000.00 | - |
| Cash at end of period | 3.28 Million | 3344.00 | 100.01 Thousand | 36 Thousand |
| Capital Expenditure | -15.25 Thousand | -121.26 Thousand | -6289.00 | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 3.27 Million | -96.66 Thousand | 97.01 Thousand | 36 Thousand |
| Free Cash Flow | -2.77 Million | -2.36 Million | -94.48 Thousand | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -417.53 Thousand | -1.39 Million | -1.44 Million | -995.27 Thousand | -2.93 Million | -354.37 Thousand |
| Depreciation & Amortization | 25.54 Thousand | 17.37 Thousand | 12.54 Thousand | 12.35 Thousand | 48.77 Thousand | 12.35 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 14.34 Thousand | 14.14 Thousand | 29.16 Thousand | 32.83 Thousand | 1079.00 |
| Change in working capital | -373.94 Thousand | -195.43 Thousand | 569.37 Thousand | -824.29 Thousand | -23.41 Thousand | -58.8 Thousand |
| Other non-cash items | 352.63 Thousand | 258.94 Thousand | -376.53 Thousand | 30.92 Thousand | 121.08 Thousand | 30.48 Thousand |
| Investing Cash Flow | - | -5492.00 | -5619.00 | - | -15.25 Thousand | - |
| Investments in PPE | 1.00 | -5492.00 | -5619.00 | - | -15.25 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.51 Million | -134.84 Thousand | 764.24 Thousand | 5.01 Million | 6.05 Million | 350.82 Thousand |
| Debt repayment | -220.72 Thousand | -134.84 Thousand | -85.88 Thousand | -485.84 Thousand | -518.75 Thousand | -939.88 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -775.48 Thousand | - | 850.12 Thousand | 5.33 Million | 5.33 Million | -589.05 Thousand |
| Other Financing Activities | 2.51 Million | -134.84 Thousand | 764.24 Thousand | 172.67 Thousand | 200.01 Thousand | 350.82 Thousand |
| Accounts receivables | -93.55 Thousand | -13.69 Thousand | 283.44 Thousand | -246.48 Thousand | -110.16 Thousand | -641.82 Thousand |
| Accounts payables | -287.18 Thousand | -145.45 Thousand | 182.57 Thousand | -491.2 Thousand | 27.4 Thousand | 295.51 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -67.07 Thousand | -36.28 Thousand | 103.35 Thousand | 34.49 Thousand | 180.43 Thousand | 287.49 Thousand |
| Cash at beginning of period | 1.59 Million | 3.23 Million | 3.28 Million | 18.01 Thousand | 3344.00 | 36.44 Thousand |
| Cash at end of period | 2.69 Million | 1.59 Million | 3.23 Million | 3.28 Million | 3.28 Million | 18.01 Thousand |
| Capital Expenditure | 1.00 | -5492.00 | -5619.00 | - | -15.25 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.1 Million | -1.64 Million | -42.11 Thousand | 3.26 Million | 3.27 Million | -18.43 Thousand |
| Free Cash Flow | -413.3 Thousand | -1.5 Million | -806.36 Thousand | -1.75 Million | -2.77 Million | -369.26 Thousand |
LEGH
002953
AMKAF
8942
MPL
STRR